Clinical trial

Resveratrol and the Metabolic Syndrome

NCT01714102

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-10-01

PhaseNA

Study timeline

Study start (actual)2012-10-01Date precision: month

Registry last updated2018-10-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Insulin Resistanceunresolved

Metabolic Syndromeunresolved

Interventions

PlaceboDIETARY_SUPPLEMENT

ResveratrolDIETARY_SUPPLEMENT

Sponsors & collaborators

Rockefeller Universitylead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01714102 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.